Delaware | 0-19311 | 33-0112644 | ||
(State or other Jurisdiction of Incorporation) |
(Commission File No.) | (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. OTHER EVENTS. | ||||||||
Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EX-99.1 PRESS RELEASE DATED AUGUST 9, 2005 |
(c) | Exhibits |
Exhibit | ||
Number | Description of Exhibit | |
99.1
|
Press Release, dated August 9, 2005, issued by Biogen Idec Inc. and Elan Corporation, plc |
BIOGEN IDEC INC. | ||||
By: | /s/ Raymond G. Arner | |||
Date: August 11, 2005
|
Name: Raymond G. Arner | |||
Title: Acting General Counsel |